首页> 外文期刊>Biotechnology Letters >Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1
【24h】

Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1

机译:表达BMP-2,VEGF和Angiopoietin-1的基因工程骨髓基质细胞增强骨形成

获取原文
获取原文并翻译 | 示例
           

摘要

To explore the potential of combined delivery of osteogenic and angiogenic factors to bone marrow stromal cells (BMSCs) for repair of critical-size bone defects, we followed the formation of bone and vessels in tissue-engineered constructs in nude mice and rabbit bone defects upon introducing different combinations of BMP-2, vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) to BMSCs with adenoviral vectors. Better osteogenesis and angiogenesis were found in co-delivery group of BMP-2, VEGF and angiopoietin-1 than any other combination of these factors in both animal models, indicating combined gene delivery of angiopoietin-1 and VEGF165 into a tissue-engineered construct produces an additive effect on BMP-2-induced osteogenesis.
机译:为了探讨成骨和血管生成因子联合递送至骨髓基质细胞(BMSC)修复临界大小骨缺损的潜力,我们追踪了裸鼠和兔骨缺损的组织工程构造中骨骼和血管的形成将带有腺病毒载体的BMP-2,血管内皮生长因子(VEGF)和血管生成素1(Ang-1)的不同组合引入BMSC。在两个动物模型中,BMP-2,VEGF和血管生成素-1的共递送组均发现比这些因子的任何其他组合更好的成骨性和血管生成,表明血管生成素-1和VEGF165的联合基因递送到组织工程构建体中对BMP-2诱导的成骨作用的累加效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号